Deutsche Bank AG reiterated a buy rating and issued a $90.00 target price on shares of salesforce.com, inc.in a report on Tuesday, January 31st. 20,000 shares valued at $1.67 million were sold by Benioff Marc on Wednesday, March 8. Needham & Company LLC initiated coverage on salesforce.com, inc.in a research report on Wednesday, February 15th. Weaver Amy E also sold $4,774 worth of salesforce.com, inc. Yates William Rufus also sold $1.77M worth of BB&T Corporation (NYSE:BBT) shares. About shares traded. Heat Biologics Inc (NASDAQ:HTBX) has risen 6.00% since April 19, 2017 and is uptrending. JNBA Financial Advisors increased its position in shares of salesforce.com, inc.by 9.3% in the fourth quarter. The shares were sold at an average price of $86.43, for a total value of $864,300.00. Analysts were expecting $2.35 billion. The firm's 50-day moving average price is $85.48 and its 200-day moving average price is $78.94.
On last trading day, Viking Therapeutics, Inc.
Trading stocks at an all time highs is usually a winning strategy. This is an increase of 165% compared to the average volume of 7,630 call options.
SAN FRANCISCO, Calif. - May 18, 2017 - Salesforce (NYSE: CRM), the global leader in CRM, today announced results for its fiscal first quarter ended April 30, 2017.
The cloud juggernaut posted a net loss of $9.2m for the quarter, with Q1 revenue increasing 25% to $2.4bn, deferred revenue for the quarter stood at $5bn, up 26% on the previous year. The company is estimating to achieve earnings per share (EPS) growth of 170.20% in this year.More news: Unsuspecting Walmart customer takes down startled deer
More news: Dunkin' Donuts now offering frozen coffee
More news: 'No. No. Next question': Trump's terse Federal Bureau of Investigation denial
"Salesforce should easily march past $10 billion in revenue this year and at this rate the road to $20 billion looks pretty clear", the firm opined. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and worldwide copyright and trademark law.
Stock is now moving with a positive distance from the 200 day simple moving average of approximately 12.86%, and has a solid year to date (YTD) performance of 28.18% which means the stock is constantly adding to its value from the previous fiscal year end price. (NYSE:CRM) for 34,085 shares. Other than it takes a remarkable amount of expertise and knowledge to be investing in these companies and being successful. BMO Capital Markets decreased their price target on salesforce.com, inc. from $100.00 to $92.00 and set an "outperform" rating for the company in a report on Monday. The share price is trading in a range of $59.10 - 60.60. Barclays Capital maintained the shares of CRM in report on Thursday, September 1 with "Overweight" rating. One investment analyst has rated the stock with a sell rating, five have given a hold rating and forty-one have given a buy rating to the company's stock. The stock now has a consensus rating of "Buy" and an average price target of $94.72.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CRM. Finally, Harfst & Associates Inc. purchased a new position in shares of salesforce.com, inc. during the first quarter worth approximately $141,000. On a GAAP basis, earnings per diluted share in this year's first quarter were $0.60, or $0.68 when adjusted for proxy contest-related expenses*, compared with $0.60 per diluted share in the first quarter of 2016. First Personal Financial Services now owns 1,611 shares of the CRM provider's stock worth $133,000 after buying an additional 112 shares during the period. The insider QUBEIN NIDO R sold 10,904 shares worth $515,577. Hemenway Trust Co LLC purchased a new position in shares of salesforce.com, inc. during the fourth quarter worth approximately $137,000.
ILLEGAL ACTIVITY WARNING: "25,915 Shares in salesforce.com, inc". Price to sales ratio was 14.10 while 73.10% of stock was owned by Institutional investors.
Salesforce.com, inc. (NYSE:CRM)'s market cap, the total dollar value of all of their outstanding shares, is 61278.46m.